| Charter Hall Retail REIT (CQR) ORDINARY UNITS FULLY PAID |
Real Estate |
$2,366 |
Substantial Holder Notice for HPI
|
23 Jan 2025 9:20AM |
$3.190 |
$4.070 |
risen by
27.59%
|
|
| Hotel Property Investments (HPI) ORDINARY FULLY PAID |
Real Estate |
- |
Substantial Holder Notice from CQR
|
23 Jan 2025 9:20AM |
$3.750 |
$3.750 |
fallen by
0%
|
|
| Bubalus Resources Limited (BUS) ORDINARY FULLY PAID |
Materials |
$10 |
Proposed issue of securities - BUS
|
23 Jan 2025 9:19AM |
$0.155 |
$0.140 |
fallen by
9.68%
|
|
| EPX Limited (EPX) ORDINARY FULLY PAID |
Information Technology |
$23 |
December 2024 Quarterly Activity Report and Appendix 4C
|
23 Jan 2025 9:19AM |
$0.022 |
$0.280 |
risen by
1,172.73%
|
|
EPX - Price-sensitive ASX Announcement
Full Release
Key Points
- Positive net operating cash inflows of $0.4 million for the December 2024 quarter.
- Cash receipts from customers reached $4.5 million, up 11% over December 2023.
- Six months year-to-date net operating cash inflow is $0.9 million, up 37% on prior corresponding period.
- Raised $1.0 million via private placement to fund growth.
- Total cash on hand at December 31, 2024, was $2 million.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Incitec Pivot Limited (IPL) ORDINARY FULLY PAID |
Materials |
$4,827 |
Update - Notification of buy-back - IPL
|
23 Jan 2025 9:18AM |
$3.040 |
$2.590 |
fallen by
14.80%
|
|
| Nanoveu Limited (NVU) ORDINARY FULLY PAID |
Information Technology |
$83 |
Change of Director's Interest Notice
|
23 Jan 2025 9:17AM |
$0.031 |
$0.084 |
risen by
170.97%
|
|
| Rhythm Biosciences Limited (RHY) ORDINARY FULLY PAID |
Health Care |
$44 |
Quarterly Activities Report and Appendix 4C - Dec24
|
23 Jan 2025 9:16AM |
$0.091 |
$0.135 |
risen by
48.35%
|
|
RHY - Price-sensitive ASX Announcement
Full Release
Key Points
- Received $3.2m R&D Tax Incentive.
- Completed placement raising $3.5m.
- Board renewal with new director Gavin Fox-Smith.
- Delivered 2nd Generation ColoSTAT® Beta Release candidate Multiplex Kits.
- Acquired Genetype business assets enhancing diagnostic capabilities.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Golden Mile Resources Ltd (G88) ORDINARY FULLY PAID |
Materials |
$4 |
SIGNIFICANT GOLD TARGET IDENTIFIED AT PEARL COPPER PROJECT
|
23 Jan 2025 9:16AM |
$0.007 |
$0.006 |
fallen by
14.29%
|
|
G88 - Price-sensitive ASX Announcement
Full Release
Key Points
- Aurora Prospect identified with high-grade gold and silver assays.
- Sampling returned results of up to 10.8 g/t Au and 33.9 g/t Ag.
- Located 800m east of Pearl Mine workings at Odyssey Prospect.
- Further sampling at Ford Prospect also yielded promising results.
- Pearl Copper Project has significant historical mining activity.
- Drilling permits have been submitted to commence exploration.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Golden Horse Minerals Limited (GHM) CHESS DEPOSITARY INTERESTS 1:1 |
Materials |
$174 |
First Drill Campaign Completed Within Weeks Of ASX Listing
|
23 Jan 2025 9:14AM |
$0.225 |
$0.755 |
risen by
235.56%
|
|
GHM - Price-sensitive ASX Announcement
Full Release
Key Points
- First drill campaign completed within weeks of ASX listing.
- Initial exploration drilling at Hakes Find totaled 1,219 meters.
- Ongoing exploration targets set for the next 12-18 months.
- Drilling at Hopes Hill expected to commence in February 2025.
- Over 1,000 soil samples collected for multi-element analysis.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Morphic Ethical Equities Fund Limited (MEC) ORDINARY FULLY PAID |
Financials |
$37 |
Update - Notification of buy-back - MEC
|
23 Jan 2025 9:14AM |
$1.085 |
$1.165 |
risen by
7.37%
|
|
| Felix Gold Limited (FXG) ORDINARY FULLY PAID |
Materials |
$175 |
High-grade Antimony and Gold Results from Trenching
|
23 Jan 2025 9:12AM |
$0.140 |
$0.355 |
risen by
153.57%
|
|
FXG - Price-sensitive ASX Announcement
Full Release
Key Points
- Completed trenching program at Treasure Creek Project with significant results.
- Notable findings include 3m at >35% Sb and 5.29 g/t Au.
- High-grade antimony and gold mineralization confirmed in multiple trenches.
- Historical Scrafford Antimony Mine shows potential for high-grade production.
- Strategic importance of antimony for U.S. national security emphasized.
- Plans for further sampling and metallurgical studies to guide production strategies.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Resolute Mining Limited (RSG) ORDINARY FULLY PAID |
Materials |
$2,609 |
Quarterly Conference Call Details
|
23 Jan 2025 9:11AM |
$0.405 |
$1.225 |
risen by
202.47%
|
|
| Great Divide Mining Ltd (GDM) ORDINARY FULLY PAID |
Materials |
$15 |
Completion of Due Diligence on Adelong Gold Project
|
23 Jan 2025 9:07AM |
$0.310 |
$0.300 |
fallen by
3.23%
|
|
GDM - Price-sensitive ASX Announcement
Full Release
Key Points
- Due Diligence at Adelong mine site completed by GDM
- Results of due diligence are considered satisfactory
- Due Diligence results will enable binding agreements to proceed
- GDM took a hands-on approach during the due diligence process
- Several key pieces of equipment already re-commissioned
- GDM will acquire a 15% holding in CMPL
- GDM's focus will be on moving the Adelong Gold Mine back into production
- GDM thanks its Shareholders and ADG for their cooperation
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| BPH Global Ltd (BP8) ORDINARY FULLY PAID |
Health Care |
$4 |
Completion of Indonesian Seaweed Joint Venture Transaction
|
23 Jan 2025 9:06AM |
$0.002 |
$0.002 |
fallen by
0%
|
|
BP8 - Price-sensitive ASX Announcement
Full Release
Key Points
- Indonesian-based seaweed joint venture transaction completed
- Development and expansion of seaweed business initiated
- 100% owned subsidiary in Indonesia established
- Focus on sales agreements for raw seaweed to Asian markets
- Development of seaweed-based bio-stimulant products for Indian market
- 10 million shares issued to joint venture partners
- Acquisition involves transfer of joint venture partners' assets
- Employment agreement signed with operations manager for the Indonesian subsidiary
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Halo Technologies Holdings Ltd (HAL) ORDINARY FULLY PAID |
Financials |
$10 |
Change of Company Secretary
|
23 Jan 2025 9:05AM |
$0.046 |
$0.033 |
fallen by
28.26%
|
|
| Coast Entertainment Holdings Limited (CEH) ORDINARY FULLY PAID |
Consumer Discretionary |
$214 |
Update - Notification of buy-back - CEH
|
23 Jan 2025 9:05AM |
$0.465 |
$0.550 |
risen by
18.28%
|
|
| Nova Minerals Limited (NVA) ORDINARY FULLY PAID |
Materials |
$360 |
Further High-Grade Gold Discovered at Wombat up to 360g/t Au
|
23 Jan 2025 9:02AM |
$0.345 |
$0.790 |
risen by
128.99%
|
|
NVA - Price-sensitive ASX Announcement
Full Release
Key Points
- 2024 sampling at Wombat reveals high-grade gold up to 360 g/t Au.
- Seven rock samples greater than 2 g/t Au were recorded.
- A lab discrepancy corrected a previous sample reporting 298 g/t Au.
- Gallium values found at Wombat are significant, with a high of 74.5 ppm.
- The Estelle project is focused on both gold and critical minerals.
- Wombat prospect shows potential for further exploration and drilling.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| EZZ Life Science Holdings Limited (EZZ) ORDINARY FULLY PAID |
Health Care |
$67 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
23 Jan 2025 9:02AM |
$2.300 |
$1.410 |
fallen by
38.70%
|
|
EZZ - Price-sensitive ASX Announcement
Full Release
Key Points
- Receipts from customers totalled $15.8m for Q2 FY25, up 16.6% on the previous corresponding period.
- Operating cash flows rose to $1.6m, marking a 308% increase on the previous corresponding period.
- EZZ's cash position remained robust with a new record balance of $19.9m at 31 December 2024 and no debt.
- Successfully launched four innovative products during the quarter.
- Expanded retail presence by securing listings in 14 new independent pharmacies.
- Advanced plans for entering the US market with a strategy scheduled for execution in H2 FY25.
- Achieved 84% year-on-year revenue increase during the 2025 11.11 Global Shopping Festival.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Regal Investment Fund (RF1) ORDINARY UNITS FULLY PAID |
Financials |
$721 |
Update - Dividend/Distribution - RF1
|
23 Jan 2025 9:02AM |
$3.290 |
$3.420 |
risen by
3.95%
|
|
| Premier Investments Limited (PMV) ORDINARY FULLY PAID |
Consumer Discretionary |
$2,205 |
PMV General Meeting - Voting Update
|
23 Jan 2025 9:01AM |
$27.050 |
$13.790 |
fallen by
49.02%
|
|
| Powerhouse Ventures Limited (PVL) ORDINARY FULLY PAID |
Financials |
$24 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
23 Jan 2025 9:01AM |
$0.094 |
$0.150 |
risen by
59.57%
|
|
PVL - Price-sensitive ASX Announcement
Full Release
Key Points
- NTA uplift to 10.4 cents per share.
- Completion of Aliwa Funds acquisition.
- Merger of Revaia with Regenco to enhance carbon project development.
- Sale of CourseLoop investment for $790,000.
- Active investment in Metal Powder Works.
- Transition to a broader funds management business.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Imricor Medical Systems Inc (IMR) CDI 1:1 US PERSON PROHIBITED EXCLUDING QIB |
Health Care |
$491 |
Imricor Q4 CY24 Quarterly Activities Report and Appendix 4C
|
23 Jan 2025 9:01AM |
$1.335 |
$1.530 |
risen by
14.61%
|
|
IMR - Price-sensitive ASX Announcement
Full Release
Key Points
- US FDA review of Imricor’s first module completed successfully
- First MRI guided ablation in Switzerland performed at CHUV
- Consumables revenue of $255k up over 840% on Q4 2023
- Total revenue of $280k
- Cash balance of US$15.7m as at 31 December 2024
- Regulatory progress in Europe and the US continues
- Successful entry into Middle East market with sales in Qatar
- Imricor aims for significant milestones in 2025
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.
| Golden Mile Resources Ltd (G88) ORDINARY FULLY PAID |
Materials |
$4 |
Application for quotation of securities - G88
|
23 Jan 2025 8:58AM |
$0.007 |
$0.006 |
fallen by
14.29%
|
|
| Resolution Minerals Ltd (RML) ORDINARY FULLY PAID |
Materials |
$99 |
Notification of cessation of securities - RML
|
23 Jan 2025 8:58AM |
$0.011 |
$0.049 |
risen by
345.45%
|
|
| Tinybeans Group Ltd (TNY) ORDINARY FULLY PAID |
Communication Services |
$15 |
Quarterly Activities/Appendix 4C Cash Flow Report
|
23 Jan 2025 8:58AM |
$0.075 |
$0.081 |
risen by
8%
|
|
TNY - Price-sensitive ASX Announcement
Full Release
Key Points
- Q2 FY25 subscription revenue increased by 9% to US$0.80 million.
- Blended renewal rate for paid subscribers was 92%.
- Cash burn reduced to -US$231k.
- EBITDA improved to -US$445k, a 43% improvement year-on-year.
- Major restructure completed to streamline operations.
- Launched Tinybeans+ gift cards with promising early sales.
- Executed successful marketing partnerships in Australia.
- Key marketing initiatives set to drive growth in Q3.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should
refer to the full announcement here for further information.